Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
15 August 1995 | Volume 123 Issue 4 | Pages 269-273
Objective: To determine the sensitivity of calcium injected into pancreatic arteries in localizing insulin-secreting tumors to regions of the pancreas.
Design and Patients: To stimulate the release of insulin, 25 patients with surgically proven insulinomas (average diameter, 15 mm) had calcium gluconate (0.025 mEq Ca++/kg body weight) injected before surgery into the arteries supplying the pancreatic head (gastroduodenal and superior mesenteric arteries) and the body and tail (splenic artery) of the pancreas.
Setting: Tertiary referral hospital.
Measurements: Insulin levels were measured in samples taken from the right and left hepatic veins before and 30, 60, and 120 seconds after calcium injection. A twofold increase in insulin level in the sample taken from the right hepatic vein 30 or 60 seconds after injection localized the insulinoma to the segment of the pancreas supplied by the selectively injected artery. Localization done using calcium stimulation was compared with localization done using transcutaneous ultrasonography (n = 22), computed tomography (n = 23), magnetic resonance imaging (n = 21), arteriography (n = 25), and portal venous sampling (n = 9).
Results: Calcium stimulation localized 22 of 25 insulinomas (sensitivity, 88% [95% CI, 68% to 97%]) to the correct region of the pancreas. The sensitivities of the other imaging methods were 9% for ultrasonography (CI, 1% to 23%), 17% for computed tomography (CI, 5% to 39%), 43% for magnetic resonance imaging (CI, 22% to 66%), 36% for arteriography (CI, 18% to 57%), and 67% for portal venous sampling (CI, 30% to 93%). Calcium stimulation added only a few minutes to the time needed for pancreatic arteriography and caused no morbid conditions.
Conclusion: Intra-arterial calcium stimulation with right hepatic vein sampling for insulin gradients is the most sensitive preoperative test for localizing insulinomas.
Author and Article Information
From the National Institutes of Health and the National Naval Medical Center, Bethesda, Maryland, and Washington University, St. Louis, Missouri.
ARTICLE
Localization of Insulinomas to Regions of the Pancreas by Intra-arterial Stimulation with Calcium
![]()
Requests for Reprints: John L. Doppman, MD, Diagnostic Radiology Department, Clinical Center, National Institutes of Health, Building 10, Room 1C660, 10 Center Drive, MSC 1182, Bethesda, MD 20892-1182.
Acknowledgments: The authors thank Carla Hendricks, who did the insulin radioimmunoassays and assisted with analysis of the data; Dr. Samuel Wells of Washington University, St. Louis, Missouri, who provided helpful discussion during our selection of the most appropriate secretagogue; and Dr. Charles Lucas of Wayne State University, Detroit, Michigan, who provided surgical and histologic data for one patient.
Related articles in Annals:
This article has been cited by other articles:
![]() |
P. Kar, P. Price, S. Sawers, S. Bhattacharya, R. H. Reznek, and A. B. Grossman Insulinomas May Present with Normoglycemia after Prolonged Fasting but Glucose-Stimulated Hypoglycemia J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4733 - 4736. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Scarsbrook, R. V. Thakker, J. A. H. Wass, F. V. Gleeson, and R. R. Phillips Multiple Endocrine Neoplasia: Spectrum of Radiologic Appearances and Discussion of a Multitechnique Imaging Approach. RadioGraphics, March 1, 2006; 26(2): 433 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cucchiaro, S. D. Markowitz, R. Kaye, N. S. Adzick, R. S. Litman, C. A. Stanley, and M. F. Watcha Blood Glucose Control During Selective Arterial Stimulation and Venous Sampling for Localization of Focal Hyperinsulinism Lesions in Anesthetized Children Anesth. Analg., October 1, 2004; 99(4): 1044 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Kaltsas, G. M. Besser, and A. B. Grossman The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors Endocr. Rev., June 1, 2004; 25(3): 458 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Stanley, P. S. Thornton, A. Ganguly, C. MacMullen, P. Underwood, P. Bhatia, L. Steinkrauss, L. Wanner, R. Kaye, E. Ruchelli, et al. Preoperative Evaluation of Infants with Focal or Diffuse Congenital Hyperinsulinism by Intravenous Acute Insulin Response Tests and Selective Pancreatic Arterial Calcium Stimulation J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 288 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Power and R H Reznek Imaging pancreatic islet cell tumours Imaging, April 1, 2002; 14(2): 147 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Witteles, F. H. Straus II, S. L. Sugg, M. R. Koka, E. A. Costa, and E. L. Kaplan Adult-Onset Nesidioblastosis Causing Hypoglycemia: An Important Clinical Entity and Continuing Treatment Dilemma Arch Surg, June 1, 2001; 136(6): 656 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, A. Kishi, Y. Nishio, H. Maegawa, K. Egawa, N. C. W. Wong, H. Kojima, M. Fujimiya, R. Arai, A. Kashiwagi, et al. Insulin Production in a Neuroectodermal Tumor that Expresses Islet Factor-1, But Not Pancreatic-Duodenal Homeobox 1 J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1795 - 1800. [Abstract] [Full Text] |
||||
![]() |
S. U. Goebel, P. L. Peghini, P. K. Goldsmith, A. M. Spiegel, F. Gibril, M. Raffeld, R. T. Jensen, and J. Serrano Expression of the Calcium-Sensing Receptor in Gastrinomas J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4131 - 4137. [Abstract] [Full Text] |
||||
![]() |
B. Hirshberg, A. Livi, D. L. Bartlett, S. K. Libutti, H. R. Alexander, J. L. Doppman, M. C. Skarulis, and P. Gorden Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3222 - 3226. [Abstract] [Full Text] |
||||
![]() |
F. J. Service, N. Natt, G. B. Thompson, C. S. Grant, J. A. van Heerden, J. C. Andrews, E. Lorenz, A. Terzic, and R. V. Lloyd Noninsulinoma Pancreatogenous Hypoglycemia: A Novel Syndrome of Hyperinsulinemic Hypoglycemia in Adults Independent of Mutations in Kir6.2 and SUR1 Genes J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1582 - 1589. [Abstract] [Full Text] |
||||